Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Mesoblast Limited (MESO)

  • Business News
  • Nov. 20, 2025, 22:54 UTC
  • 18
  • 1 comments

Mesoblast & BMT CTN to Initiate Adult aGvHD Trial of RYONCIL

Market reaction Comment Full text

Exact Sciences Corporation (EXAS)

  • Business News
  • Nov. 20, 2025, 22:27 UTC
  • 10
  • 0 comments

DEFA14A (Additional Proxy Soliciting Materials (definitive)) SEC Filing

Market reaction Comment Full text

RespireRx Pharmaceuticals Inc. (RSPI)

  • Business News
  • Nov. 20, 2025, 22:19 UTC
  • 15
  • 1 comments

RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties

Market reaction Comment Full text

Clearpoint Neuro Inc (CLPT)

  • Business News
  • Nov. 20, 2025, 22:00 UTC
  • 8
  • 0 comments

ClearPoint Neuro Completes Acquisition of IRRAS

Market reaction Comment Full text

Exact Sciences Corporation (EXAS)

  • Business News
  • Nov. 20, 2025, 21:56 UTC
  • 8
  • 0 comments

DEFA14A (Additional Proxy Soliciting Materials (definitive)) SEC Filing

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • Business News
  • Nov. 20, 2025, 21:42 UTC
  • 8
  • 0 comments

UTHR: Notification

Market reaction Comment Full text

Equillium Inc. (EQ)

  • Business News
  • Nov. 20, 2025, 21:35 UTC
  • 8
  • 0 comments

Equillium - Equillium to Participate in Upcoming Investor Conferences

Market reaction Comment Full text

Equillium Inc. (EQ)

  • Business News
  • Nov. 20, 2025, 21:35 UTC
  • 15
  • 1 comments

Equillium to Participate in Upcoming Investor Conferences

Market reaction Comment Full text

ResMed Inc (RMD)

  • Business News
  • Nov. 20, 2025, 21:31 UTC
  • 8
  • 0 comments

New SEC Form for ResMed Inc.

Market reaction Comment Full text

Quanterix Corp (QTRX)

  • Business News
  • Nov. 20, 2025, 21:15 UTC
  • 14
  • 1 comments

Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

Market reaction Comment Full text
  • Previous
  • 544
  • 545
  • 546
  • 547
  • 548
  • Next

Search

News categories

  • Technical Exchange News(10945)
  • Event(2382)
  • SEC News(191985)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125295)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin